Fundamental Data for ONXX

ONYX PHARM(NSDQ:ONXX)

Onyx Pharmaceuticals, Inc is developing innovative products for the treatment of cancer.

# Employees: 197

Address: 2100 Powell Street,Emeryville,CA,USA

Phone: 510 597-6500

Fax: 510-597-6600

Website: www.onyx-pharm.com

Email: IR@onyx-pharm.com

Sector: Medical

Industry: MED-DRUGS

Executive Officers

Hollings C. Renton (Chmn.; Presi.; C.E.O.)

Gregory W. Schafer (V.P.; C.F.O.; Princ. Acctg. Off.)

Paul Goddard Ph.D. (Dir.)

Antonio Grillo-lopez M.D. (Dir.)

Magnus Lundberg (Dir.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 2/22/2010

Mean EPS (Next Qtr): $0.22

Mean EPS (Year): $0.62

Mean Estimate(Long Term): $23.33

P/E Ratio(Based on EPS estimate): 44.930

Number of Estimates: 10

Shares Performance

Period	ONXX	Compare to S&P
YTD	-18.06 %	-32.19 %
4 Weeks	10.15 %	8.96 %
12 Weeks	-11.31 %	-16.39 %

Shares Information

Analyst Coverage: Y

Avg Volume: 1138891

Shares Outstanding: 61M

Market Cap: $1.71B

52 Week High: $36.55

52 Week Low: $22.17

P/E Ratio: -0.010

PEG Ratio: 1.930

Split: On 1/1/1990 ONXX split by factor of 2.000

Earnings Performance

EPS Growth in Last Quarter: 75.00 %

EPS Growth in Last Year: 33.33 %

Sales Growth in Last Quarter: 14.81 %

Sales Growth in Last Quarter: 73.17 %

Financials

Qtr Book Value: $2.29

Cash Flow/Share: $481.71

Change in Payout Ratio: -0.010

Price/Sales: 7.350